adcetris annual cost
Now, a new entrant may become the focal point of controversy. This morning, Seattle Genetics disclosed that the annual cost for Adcetris, which the FDA approved late last week to combat Hodgkinâs disease and another rare lymphoma, will cost $13,500 per dose. In clinical trials, patients received an average of eight infusions, which works out to $108,000 a year, which Xconomy reports was in line with several Wall Street estimates.